Ignite Creation Date:
2025-12-24 @ 3:55 PM
Ignite Modification Date:
2026-01-12 @ 9:53 PM
Study NCT ID:
NCT00267592
Status:
COMPLETED
Last Update Posted:
2016-05-19
First Post:
2005-12-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy of Talampanel in Glioblastoma Multiforme
Sponsor:
Teva Branded Pharmaceutical Products R&D, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-12
Start Date Type:
None
Primary Completion Date:
2008-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-02
Completion Date Type:
ACTUAL
First Submit Date:
2005-12-19
First Submit QC Date:
None
Study First Post Date:
2005-12-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2011-08-23
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2016-04-20
Last Update Post Date:
2016-05-19
Last Update Post Date Type:
ESTIMATED